NTL: revenue down 59.9% to NZ$1,191 while NPAT loss widened 39.8% to NZ$1.07m

What changed

• Revenue fell 59.9% to NZ$1,191 (FY21: NZ$2,973) — a figure too small to be operationally meaningful in either year.
• Operating loss widened 39.7% to NZ$1,062.8k, and NPAT loss widened 39.8% to NZ$1,065.9k. The PBT-to-NPAT gap is NZ$3.1k (FY21: NZ$1.5k), so tax is not distorting the read.
• Cash fell 55.7% to NZ$492.5k from NZ$1,110.7k, a NZ$618.2k draw in the year.
• Total equity eased 1.9% to NZ$14.9m; total assets fell 1.4% to NZ$15.2m; total liabilities rose 36.5% to NZ$279.0k off a small base.
• No dividend was declared (FY21: nil).

What matters

1. Cash burn vs. treasury. The NZ$618.2k cash outflow against a NZ$1.07m reported loss leaves roughly six months of runway at current run-rate, absent further financing. Prior-year operating cash outflow was NZ$696.1k; FY22 operating cash flow was not disclosed in the extraction, so cash-burn quality cannot be directly verified.
2. No operating business to speak of. Revenue at four-digit NZD scale means the earnings line is effectively a pure cost-base disclosure. The 39.8% deterioration in NPAT reflects widening costs, not a swing in operating mix.
3. Balance-sheet direction is softening on both sides. Equity is eroding through retained losses (accumulated deficit now NZ$23.6m per HY22 disclosure), while liabilities rose 36.5% year-on-year — a small absolute move, but directionally consistent with working-capital strain.

Expectations

No stated targets, forward-work, or guidance were disclosed in the release. Against the HY22 shape, the second half ran slightly worse than the first on both revenue (55.6% of the year fell in H1) and NPAT (H1 carried 49.3% of the loss, implying a NZ$540.8k H2 loss versus NZ$525.1k in H1). There is no discernible seasonality or improving trajectory in the shape disclosed — the run-rate simply continued.

Quality of result

Almost nothing in this result looks durable in a positive sense. Revenue is immaterial, no EBITDA or adjusted measure was disclosed, and no non-recurring items were flagged, so the loss appears to be a clean reflection of ongoing corporate and/or exploration costs. FX provided a NZ$13.2k cash-flow tailwind (FY21: NZ$4.7k drag), which is the only identifiable timing benefit and is small in context. FY22 operating cash flow, capex, trade debtors and gross borrowings were not disclosed in the extraction, so cash conversion cannot be directly assessed — the NZ$618.2k cash decline versus the NZ$1.07m loss is the only available proxy and is broadly in line.

Unresolved

• What is being funded? With revenue at NZ$1,191, the cost base is effectively the business; no segment, project, or forward-work disclosure clarifies the activity.
• FY22 operating cash flow, capex, and working-capital detail are not in the extracted disclosure, leaving cash quality only indirectly visible.
• The 36.5% rise in liabilities (NZ$74.7k) is not decomposed — trade payables, accruals, or related-party amounts are not broken out.
• No stated financing plan is disclosed against a cash position that has halved; the near-term capital path is unaddressed.
• This briefing cannot assess the strategic rationale for the ongoing cost base or the likelihood and terms of any capital raise required to extend runway.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.